Filed by Mylan N.V.
Pursuant to Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Mylan N.V.
Commission File No.: 333-199861
The following communications are being filed in connection with the proposed business combination between Mylan N.V. and Upjohn Inc., Pfizer Inc.s
off-patent branded and generic established medicines business.
Mylan (@MylanNews) posted the
following tweet on Twitter on December 18, 2019
@Pfizer and Mylan announce two future Viatris board members. Visit
https://www.championforglobalhealth.com/en/materials/press-releases for more important information.
Mylan posted the following message on LinkedIn
on December 18, 2019
Pfizer and Mylan announce two future Viatris board members. Visit
https://www.championforglobalhealth.com/en/materials/press-releases for more important information.
Mylan Investor Relations posted the following
message on LinkedIn on December 18, 2019
Pfizer and Mylan announce two future Viatris board members. Visit
https://www.championforglobalhealth.com/en/materials/press-releases for more important information.
Forward-Looking Statements
These communications contain forward-looking statements. Such forward-looking statements may include, without limitation, statements about the
proposed combination of Upjohn Inc. (Newco) and Mylan N.V. (Mylan), which will immediately follow the proposed separation of the Upjohn business (the Upjohn Business) from Pfizer Inc. (Pfizer) (the
proposed transaction), the expected timetable for completing the proposed transaction, the benefits and synergies of the proposed transaction, future opportunities for the combined company and products and any other statements regarding
Pfizers, Mylans, the Upjohn Businesss or the combined companys future operations, financial or operating results, capital allocation, dividend policy, debt ratio, anticipated business levels, future earnings, planned
activities, anticipated growth, market opportunities, strategies, competitions, and other expectations and targets for future periods. Forward-looking statements may often be identified by the use of words such as will, may,
could, should, would, project, believe, anticipate, expect, plan, estimate, forecast, potential,
pipeline, intend, continue, target, seek and variations of these words or comparable words. Because forward-looking statements inherently involve risks and uncertainties, actual future
results may differ